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doi:10.1016/j.jtcvs.2004.04.008There is much evidence that gender differences become manifest veryearly in life; in fact, they may begin before life. Sperm carrying theX chromosome differ in motility from the Y chromosome–bearingsperm.1,2 Once the ovum is fertilized, genetically normal malefetuses have a higher death rate than female fetuses.3 Neonatologistshave long noted gender differences in their practice. Boys are more
likely to be delivered prematurely.4 Deaths resulting from respiratory distress
syndrome5 and neonatal neurologic complications6 are greater for boys. Preterm
girls have higher levels of beneficial catecholamines than boys,7 and this may
account for their better outcomes.
Despite these indications that gender may affect the impact of disease in children,
investigations into gender influences in congenital heart disease (CHD) are sparse.
When compared with information on gender differences in adult acquired heart
disease incidence, treatment, and outcome, there is a relative dearth of information
regarding these data in congenital or acquired heart disease in children. The reason
for this is likely due to multiple factors and is probably broader than the assumption
that before adolescence, the cardiovascular physiology is unaffected by gender. For
instance, the delay in diagnosis and treatment in women with ischemic heart disease
that was so well documented in the 1990s is not likely to be found in infant girls
with significant heart disease, because the presentation of CHD is often quite
objective. Treatment in adult cardiology may have been biased in the past by
exclusion of women from randomized drug trials, yet prospective clinical trials are
much less common in pediatric cardiology8 for many reasons, including small
numbers of patients, lack of treatment uniformity both between centers and over
time within centers, and the need for multicenter trials. When a prospective clinical
trial is performed, patient recruitment is difficult enough that exclusion of one
gender is practically unthinkable.
Despite the paucity of investigations, there are aspects of CHD in which a gender
effect is known or suspected.
Incidence
Approximately 32,000 infants in this country are born each year with CHD, making
it the leading cause of birth defects. This equates to 8 cases per 1000 live births of
the more than 4 million children born yearly in this country. Nearly 40% of patients
with CHD will require a surgical intervention to palliate or correct their condition
at some point during their lifetime. This accounts for more than 20,000 yearly
surgical procedures performed in the United States for CHD.
Patterns of gender predominance have been noted in several cardiovascular
malformations, and these are summarized in Table 1. Several consistencies appear:
D-transposition of the great arteries, left-sided obstructions, and double-outlet right
ventricle have a strong male predominance, whereas more girls present with patent
ductus arteriosus, secundum atrial septal defect, and Ebstein anomaly of the tricus-
pid valve. Other lesions, such as ventricular septal defect and truncus, seem to be
equally distributed between sexes. The reasons for these observed patterns have not
been identified.
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LGenetic Syndromes and CHD
The pathogenesis of CHD is complex. Although in most
cases no underlying cause is identified, a number of well-
described genetic syndromes are known to have associated
cardiovascular malformations. Some of these include
Down, DiGeorge, Holt-Oram, Noonan, Willliam, and
Marfan syndromes. In most autosomal disorders, no signif-
icant gender predominance is recognized. Aneuploidy of the
sex chromosomes, however, results in particular gender
phenotypes that may exhibit specific patterns of cardiovas-
cular malformations: such is the case with Turner syndrome.
Turner syndrome is a chromosomal disorder that exclu-
sively affects girls and women. It is associated with mono-
somy of the X chromosome (XO karyotype), mosaicism, or
structural abnormalities of the X chromosome, such as
partial deletion or ring formation. Structural heart disease
occurs in approximately 25% of patients with Turner syn-
drome: the most common are bicuspid aortic valve, coarc-
tation of the aorta, aortic root dilation, and more severe
forms of left-sided obstruction, such as hypoplastic left
heart syndrome. An even higher incidence of CHD (62%)
has been identified prenatally by fetal echocardiography.12
The typical fetal presentation of Turner syndrome has an
extremely poor prognosis for intrauterine survival.12
An increased risk of ischemic heart disease, hyperten-
sion, stroke, type 2 diabetes, and aortic dissection has been
reported in patients with Turner syndrome; this may be due
in part to insulin resistance.13 The increased prevalence of
coronary artery disease in these women has been attributed
to the effects of premature ovarian failure. However, a
TABLE 1. The gender ratio observed for specific types of






All 1.09:1 1:1 1.28:1
PDA 1:1.7
ASD, secundum 1:1.4 1:1.5
VSD 1:1.11 1:1
Aortic stenosis 1.95:1 1.6:1
CoA 1.3:1 1.6:1
HLHS 2.6:1 1.4:1
Pulmonary atresia 1.55:1 1.14:1 1.7:1
Tricuspid atresia 1.45:1
Ebstein anomaly 1:1.6
TOF 1:1.1 1.04:1 1.4:1
DORV 2.7:1 1.7:1
TGA 2.11:1 2.23:1 2.1:1
Truncus arteriosus 1:1.2 1:1.11 1.3:1
PDA, Patent ductus arteriosus; ASD, atrial septal defect; VSD, ventricular
septal defect; CoA, coarctation of the aorta; HLHS, hypoplastic left heart
syndrome; TOF, tetralogy of Fallot; DORV, double-outlet right ventricle;
TGA, transposition of the great arteries.recent report demonstrated unfavorable lipid profiles in
8 The Journal of Thoracic and Cardiovascular Surgery ● July 20healthy, young, nonobese women with Turner syndrome,
suggesting that this may also play a role in their cardiovas-
cular morbidity.14 Current recommendations are for all pa-
tients with Turner syndrome—regardless of age, CHD, or
aortic root dilation—to undergo routine cardiovascular sur-
veillance.
Natural History of CHD
The clinical outcome in CHD is strongly influenced by the
anatomic diagnosis and the likelihood of successful pallia-
tion or “correction.” Whereas the influence of cardiac diag-
nosis is a more likely determinant than gender of mortality,
other differences in the long-term status and care may be
related to gender. In a recent multi-institutional study on
1245 adults with CHD, women were more likely to be
married, insured, or both, whereas men were more likely to
take antihypertensive drugs, afterload-reducing agents, and
antiarrhythmic drugs.15
Many studies show no gender effect on morbidity in
patients with CHD, such as a study of 495 patients who
underwent surgery for tetralogy of Fallot/pulmonary atresia
between 1977 and 1999.16 More recent data indicate that
girls are at a higher risk for hospital mortality, for reasons
that are unclear.17 This seems to be mirrored in another
study of outcomes for CHD patients who required postop-
erative extracorporeal membrane oxygenator support. This
study reported an increased risk of death by a factor of 5.43
for female patients.18 The companion editorial in this issue
by Azakie and colleagues addresses the effect of gender on
surgery for congenital heart disease.
Arrhythmias
Increasing evidence for gender-related differences in car-
diovascular disease extends to the area of electrophysiology
and arrhythmias. In one small series of perinatal supraven-
tricular tachycardia (33 patients), a male/female ratio of
2.7:1 was noted.19 Congenital third-degree atrioventricular
block overall has a slight female dominance (66% in one
large series20), and all patients were female in a study of
acquired childhood complete heart block with a recent his-
tory of viral illness.21
A prevalence of women among adult symptomatic pa-
tients with long QT syndrome is well described. Adult
women have a longer QT interval and are more prone than
men to the development of torsades de pointes. But are these
differences present at birth? A study designed to address
this question demonstrated slightly higher heart rates in
female infants than in male infants but failed to identify
disparity in the corrected QT interval (QTc) among babies
by gender.22 This suggests a potential hormonal influence
on the QTc that is possibly initiated around the time of
puberty. It is also recognized that the specific long QT
syndrome genotype influences the probability of cardiac
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Levents differently in female and male children.23 A lower
incidence of cardiac events during childhood for female
patients with the LTQS-1 variant has been reported,
whereas it is higher in women during adulthood than in
men. These types of data, along with many other observa-
tions, underscore the role of gender-specific differences in
the nature and frequency of specific cardiac rhythm disor-
ders.
Exercise and Esteem
In healthy children, boys have better exercise performance
than girls because of their greater lean body mass, stroke
volume, and maximum oxygen consumption.24 Healthy ad-
olescent females report lower self-esteem, less exercise, and
poorer heath status than do their male peers.25 These traits
are seemingly reversed in children with CHD. Male adoles-
cents with CHD have lower perceived exercise capacity and
self-esteem. This was not true for adolescent girls with
CHD. The negative self-concept of boys with CHD may be
partly explained by reduced physical ability interfering with
peer relationships.26,27 These observations may be impor-
tant in the assessment of reported symptoms, which may in
some cases be the basis for referral for surgical intervention
when objective indications are lacking.
Pregnancy Outcomes in CHD
The assessment of outcomes during pregnancy in women
with CHD is challenged by several factors. First, there is a
wide morphologic spectrum of CHD; thus, investigators
must limit their study population to a specific physiologic
group. Even then, studies that focus on specific diagnoses
are limited by heterogeneity of the patient population with
regard to prior and current therapies (medical and surgical),
age at operation, residual defects, and physiologic variabil-
ity. Patients operated on in an earlier surgical era may have
complications or residua different from those of patients
operated on more recently. Finally, the inability to accumu-
late a large number of pregnant patients with a specific
pathologic condition at a single institution often requires
multicenter studies, and this introduces the potential prob-
lem of institution bias in outcome.
Despite the challenges confronted by these studies, it is
well documented that a significant number of women with
CHD can have a successful pregnancy with proper care.
Outcome is generally favorable in women if their functional
class and systolic ventricular function are good. Risk factors
for poor maternal/fetal outcomes include severe ventricular
dysfunction, poor functional status, uncontrolled rhythm
disturbances, cyanotic conditions, increased pulmonary vas-
cular resistance, and severe right ventricular hypertension.
The highest risk of maternal death is in patients with Eisen-
menger syndrome, for which the total estimated risk is
approximately 40%. Current recommendations state that
The Journal of Thorawomen with New York Heart Association functional class
III or IV symptoms, significant systemic ventricular dys-
function, or severe systemic atrioventricular valve regurgi-
tation should be counseled against pregnancy. Other high-
risk patients include those with severe aortic stenosis or
coarctation and those with Marfan syndrome and associated
aortic root dilatation.
Certain types of repaired CHD in the mother pose min-
imal risk. For example, after repair, the risk of pregnancy
complications in women with tetralogy of Fallot is compa-
rable with that of the general population.28,29 However,
maternal Fontan physiology may pose significant risks dur-
ing pregnancy. The modified Fontan procedure, a final
pathway for many cyanotic women in whom a biventricular
repair is not feasible, provides eventual separation of the
pulmonary and systemic circulations. Considerations in pa-
tients after the Fontan operation relate to a limited ability to
increase their cardiac output, the morbidity associated with
chronic increases of systemic venous pressures, and the
potential for development of late complications. These is-
sues raise significant concerns regarding the ability of a
pregnant post-Fontan patient to tolerate the hemodynamic
burden that accompanies pregnancy and delivery. Although
successful pregnancies have been reported in women with
good hemodynamic results, many continue to counsel
against pregnancy because of the potential risks to the
mother and her infant.30 An increased incidence of first-
trimester miscarriage has been documented in these pa-
tients.
The incidence of cardiovascular anomalies in first-degree
relatives is approximately 3%31; thus, the risk for offspring
of women with CHD is known to be higher than that
identified in the healthy population. For this reason, fetal
echocardiography is strongly advised and plays a critical
role in prenatal counseling. The risk of a child of a mother
with CHD having a cardiac lesion is higher than if the father
has CHD.
Summary
Whereas gender issues are not at the forefront of concerns
facing pediatric cardiologists and congenital heart surgeons,
there are circumstances in which gender may play a role in
the care and outcome of a patient with CHD. However, any
effect at this time is likely subtle, and large studies are
necessary to reveal any such effects. The use of large
registries and multi-institutional studies will foster investi-
gation into possible gender effects, and this may further
improve the care of these patients.
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